{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:28:30Z","timestamp":1774700910543,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Although opioids are frequently prescribed in chronic obstructive pulmonary disease (COPD), there is poor understanding regarding which individuals will experience pulmonary harm upon exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We sought to identify patient characteristics and opioid drug properties predictive of opioid-related adverse pulmonary events among older adults with chronic COPD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective, population-based, cohort study design was used, analyzing Ontario heath administrative data. Individuals aged 66 years and older, with validated, physician-diagnosed COPD receiving a new opioid drug were included. Adverse pulmonary events (defined as an emergency room visit, hospitalization, or death related to either COPD or pneumonia) occurring within 30 days following new opioid receipt were considered. Multivariable-adjusted, cause-specific hazard modeling was used to identify predictors of adverse pulmonary events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 169,517 older adults with COPD receiving a new opioid, 4,861 (2.9%) experienced an adverse pulmonary event within 30 days. Factors independently predisposing to adverse pulmonary events included older age (\u226585 yr old: hazard ratio [HR], 1.37; 95% confidence interval [CI], 1.26\u20131.49), long-term-care home residence (HR, 1.32; 95% CI, 1.21\u20131.44), severe COPD exacerbation within the preceding year (HR, 2.96; 95% CI, 2.77\u20133.17), comorbidities (including non-COPD lung disease [HR, 1.16; 95% CI, 1.09\u20131.23], congestive heart failure [HR, 1.22; 95% CI, 1.14\u20131.30], sleep disorder [HR, 1.22; 95% CI, 1.15\u20131.30], and dementia [HR, 1.14; 95% CI, 1.05\u20131.24]); other psychoactive medication receipt, including benzodiazepines (HR, 1.27; 95% CI, 1.19\u20131.35) and serotonergic antidepressants (HR, 1.10; 95% CI, 1.03\u20131.19), and receipt of an opioid-only agent (HR, 1.35; 95% CI, 1.26\u20131.46). Factors that independently protected from adverse pulmonary events included female sex (HR, 0.78; 95% CI, 0.73\u20130.82), surgery within the preceding year (HR, 0.70; 95% CI, 0.64\u20130.77), and musculoskeletal disease (HR, 0.75; 95% CI, 0.70\u20130.80). No significant associations were observed between adverse pulmonary events and opioid half-life duration or opioid daily dosage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patient and opioid drug factors predictive of opioid-related adverse pulmonary events among older adults with COPD were identified, which may assist with safer opioid prescribing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.201910-760oc","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T14:12:30Z","timestamp":1589292750000},"page":"965-973","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":7,"title":["Predictors of Opioid-related Adverse Pulmonary Events among Older Adults with Chronic Obstructive Pulmonary Disease"],"prefix":"10.1093","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1670-1592","authenticated-orcid":false,"given":"Nicholas T.","family":"Vozoris","sequence":"first","affiliation":[{"name":"Division of Respirology, Department of Medicine, and"},{"name":"Keenan Research Centre in the Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, Ontario, Canada"},{"name":"Department of Medicine and"},{"name":"ICES, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila","family":"Pequeno","sequence":"additional","affiliation":[{"name":"ICES, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[{"name":"ICES, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Austin","sequence":"additional","affiliation":[{"name":"ICES, Toronto, Ontario, Canada"},{"name":"Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis E.","family":"O'Donnell","sequence":"additional","affiliation":[{"name":"Department of Medicine, Queen\u2019s University, Kingston, Ontario, Canada; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0246-594X","authenticated-orcid":false,"given":"Andrea S.","family":"Gershon","sequence":"additional","affiliation":[{"name":"Department of Medicine and"},{"name":"ICES, Toronto, Ontario, Canada"},{"name":"Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Medicine, Sunnybrook Hospital, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"key":"2026012221284607400_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/bcp.12762","article-title":"Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study","volume":"81","author":"Vozoris","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"2026012221284607400_bib2","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.2147\/COPD.S112484","article-title":"Prescription of opioids for breathlessness in end-stage COPD: a national population-based study","volume":"11","author":"Ahmadi","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012221284607400_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1586\/17476348.2016.1143776","article-title":"The need to address increasing opioid use in elderly COPD patients","volume":"10","author":"Vozoris","year":"2016","journal-title":"Expert Rev Respir Med"},{"key":"2026012221284607400_bib4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1513\/AnnalsATS.201501-034OC","article-title":"Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease: a systematic review","volume":"12","author":"Ekstr\u00f6m","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"2026012221284607400_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/thoraxjnl-2019-213681","article-title":"Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"75","author":"Currow","year":"2020","journal-title":"Thorax"},{"key":"2026012221284607400_bib6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpainsymman.2019.10.017","article-title":"Controlled-release oxycodone vs. placebo in the treatment of chronic breathlessness-a multisite randomized placebo controlled trial","volume":"59","author":"Ferreira","year":"2020","journal-title":"J Pain Symptom Manage"},{"key":"2026012221284607400_bib7","doi-asserted-by":"crossref","first-page":"1701235","DOI":"10.1183\/13993003.01235-2017","article-title":"Effect of morphine on breathlessness and exercise endurance in advanced COPD: a randomised crossover trial","volume":"50","author":"Abdallah","year":"2017","journal-title":"Eur Respir J"},{"key":"2026012221284607400_bib8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1183\/13993003.01967-2015","article-title":"Incident opioid drug use and adverse respiratory outcomes among older adults with COPD","volume":"48","author":"Vozoris","year":"2016","journal-title":"Eur Respir J"},{"key":"2026012221284607400_bib9","doi-asserted-by":"crossref","first-page":"g445","DOI":"10.1136\/bmj.g445","article-title":"Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study","volume":"348","author":"Ekstr\u00f6m","year":"2014","journal-title":"BMJ"},{"key":"2026012221284607400_bib10","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1532-5415.2011.03586.x","article-title":"Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study","volume":"59","author":"Dublin","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"2026012221284607400_bib11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/M17-1907","article-title":"Opioid analgesic use and risk for invasive pneumococcal diseases: a nested case-control study","volume":"168","author":"Wiese","year":"2018","journal-title":"Ann Intern Med"},{"key":"2026012221284607400_bib12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1183\/09031936.00139812","article-title":"Opioids for chronic refractory breathlessness: patient predictors of beneficial response","volume":"42","author":"Johnson","year":"2013","journal-title":"Eur Respir J"},{"key":"2026012221284607400_bib13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/15412550903140865","article-title":"Identifying individuals with physcian diagnosed COPD in health administrative databases","volume":"6","author":"Gershon","year":"2009","journal-title":"COPD"},{"key":"2026012221284607400_bib14","first-page":"67","article-title":"Coding accuracy of administrative drug claims in the Ontario Drug Benefit database","volume":"10","author":"Levy","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"2026012221284607400_bib15","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1001\/archinternmed.2010.17","article-title":"Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study","volume":"170","author":"Gershon","year":"2010","journal-title":"Arch Intern Med"},{"key":"2026012221284607400_bib16"},{"key":"2026012221284607400_bib17","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2019 report","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)","year":"2019"},{"key":"2026012221284607400_bib18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"2026012221284607400_bib19","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1183\/09031936.04.00121404","article-title":"Impact of preventing exacerbations on deterioration of health status in COPD","volume":"23","author":"Spencer","year":"2004","journal-title":"Eur Respir J"},{"key":"2026012221284607400_bib20","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"key":"2026012221284607400_bib21","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1164\/ajrccm.154.4.8887592","article-title":"Outcomes following acute exacerbation of severe chronic obstructive lung disease: the SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)","volume":"154","author":"Connors","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012221284607400_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bmj.327.7414.523","article-title":"Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea","volume":"327","author":"Abernethy","year":"2003","journal-title":"BMJ"},{"key":"2026012221284607400_bib23","first-page":"3267","article-title":"Obesity and obesity-related behaviors among rural and urban adults in the USA","volume":"15","author":"Trivedi","year":"2015","journal-title":"Rural Remote Health"},{"key":"2026012221284607400_bib24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1748-0361.2012.00411.x","article-title":"Prevalence of obesity among adults from rural and urban areas of the United States: findings from NHANES (2005-2008)","volume":"28","author":"Befort","year":"2012","journal-title":"J Rural Health"},{"key":"2026012221284607400_bib25","doi-asserted-by":"crossref","first-page":"E141","DOI":"10.5888\/pcd11.140189","article-title":"Rural-urban differences in objective and subjective measures of physical activity: findings from the National Health and Nutrition Examination Survey (NHANES) 2003-2006","volume":"11","author":"Fan","year":"2014","journal-title":"Prev Chronic Dis"},{"key":"2026012221284607400_bib26","first-page":"1A","article-title":"Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease: 2008 update. Highlights for primary care","volume":"15","author":"O\u2019Donnell","year":"2008","journal-title":"Can Respir J"},{"key":"2026012221284607400_bib27","first-page":"CD002991","article-title":"Inhaled corticosteroids for stable chronic obstructive pulmonary disease","volume":"7","author":"Yang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2026012221284607400_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1476-5381.1988.tb11409.x","article-title":"Effects of codeine, morphine and a novel opioid pentapeptide BW443C, on cough, nociception and ventilation in the unanaesthetized guinea-pig","volume":"93","author":"Adcock","year":"1988","journal-title":"Br J Pharmacol"},{"key":"2026012221284607400_bib29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.mjt.0000132250.95650.85","article-title":"Opioid therapy and immunosuppression: a review","volume":"11","author":"Vallejo","year":"2004","journal-title":"Am J Ther"},{"key":"2026012221284607400_bib30","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJM197505222922106","article-title":"Diminished ventilatory response to hypoxia and hypercapnia after morphine in normal man","volume":"292","author":"Weil","year":"1975","journal-title":"N Engl J Med"},{"key":"2026012221284607400_bib31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00000542-198206000-00001","article-title":"Myocardial blood flow and oxygen consumption during high-dose fentanyl anesthesia in patients with coronary artery disease","volume":"56","author":"Sonntag","year":"1982","journal-title":"Anesthesiology"},{"key":"2026012221284607400_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1183\/09031936.00008014","article-title":"Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD","volume":"44","author":"Vozoris","year":"2014","journal-title":"Eur Respir J"},{"key":"2026012221284607400_bib33","doi-asserted-by":"crossref","first-page":"1800475","DOI":"10.1183\/13993003.00475-2018","article-title":"Serotonergic antidepressant use and morbidity and mortality among older adults with COPD","volume":"52","author":"Vozoris","year":"2018","journal-title":"Eur Respir J"},{"key":"2026012221284607400_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2458-6-155","article-title":"Gender differences in the utilization of health-care services among the older adult population of Spain","volume":"6","author":"Redondo-Sendino","year":"2006","journal-title":"BMC Public Health"},{"key":"2026012221284607400_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1345\/aph.1A113","article-title":"Gender- and age-related prescription drug use patterns","volume":"36","author":"Roe","year":"2002","journal-title":"Ann Pharmacother"},{"key":"2026012221284607400_bib36","first-page":"16","article-title":"Pattern and adherence to maintenance medication use in medicare beneficiaries with chronic obstructive pulmonary disease: 2008\u20132013","volume":"5","author":"Nishi","year":"2018","journal-title":"Chronic Obstr Pulm Dis (Miami)"},{"key":"2026012221284607400_bib37","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0025-6196(11)60749-0","article-title":"A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs","volume":"84","author":"Argoff","year":"2009","journal-title":"Mayo Clin Proc"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/17\/8\/965\/66545638\/annalsats_17_8_965.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/17\/8\/965\/66545638\/annalsats_17_8_965.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T02:29:04Z","timestamp":1769135344000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/17\/8\/965\/8418796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,1]]},"published-print":{"date-parts":[[2020,8,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201910-760oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8]]},"published":{"date-parts":[[2020,8,1]]},"assertion":[{"value":"2019-10-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}